A-018
Pill imprint A-018 has been identified as Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg.
Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; peptic ulcer; enterocolitis and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy.
Chlordiazepoxide/clidinium 5 mg / 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Chlordiazepoxide hydrochloride and clidinium bromide Images
- Imprint:
-
A-018
- Strength:
- 5 mg / 2.5 mg
- Color:
- Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Anticholinergics/antispasmodics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
Advertisement
More Chlordiazepoxide Hydrochloride and Clidinium Bromide resources
- Chlordiazepoxide Hydrochloride and Clidinium Bromide Side Effects
- Chlordiazepoxide Hydrochloride and Clidinium Bromide Use in Pregnancy & Breastfeeding
- Chlordiazepoxide Hydrochloride and Clidinium Bromide Drug Interactions
- Support Group Q & A
- 14 Reviews for Chlordiazepoxide Hydrochloride and Clidinium Bromide - Add your own review/rating
- Chlordiazepoxide/Clidinium (Wolters Kluwer)
- chlordiazepoxide and clidinium (Cerner Multum)
- chlordiazepoxide and clidinium (Micromedex) - Includes Dosage Information
- Chlordiazepoxide and Clidinium Capsules (FDA)
Search Again
